These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 17216053)
1. Design of radiolabelled ligands for the imaging and treatment of cancer. Mather SJ Mol Biosyst; 2007 Jan; 3(1):30-5. PubMed ID: 17216053 [TBL] [Abstract][Full Text] [Related]
2. Radiolabelled chemotherapeutics. Rottey S; Signore A; Van de Wiele C Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):139-51. PubMed ID: 17420715 [TBL] [Abstract][Full Text] [Related]
3. Radiolabelled Polymeric Materials for Imaging and Treatment of Cancer: Quo Vadis? Pant K; Sedláček O; Nadar RA; Hrubý M; Stephan H Adv Healthc Mater; 2017 Mar; 6(6):. PubMed ID: 28218487 [TBL] [Abstract][Full Text] [Related]
4. Targeting cytokine/chemokine receptors: a challenge for molecular nuclear medicine. Signore A; Chianelli M; Bei R; Oyen W; Modesti A Eur J Nucl Med Mol Imaging; 2003 Jan; 30(1):149-56. PubMed ID: 12520385 [TBL] [Abstract][Full Text] [Related]
5. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization. Vallabhajosula S Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348 [TBL] [Abstract][Full Text] [Related]
6. Nuclear imaging in cancer theranostics. Del Vecchio S; Zannetti A; Fonti R; Pace L; Salvatore M Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):152-63. PubMed ID: 17420716 [TBL] [Abstract][Full Text] [Related]
7. Metallic radionuclides in the development of diagnostic and therapeutic radiopharmaceuticals. Bhattacharyya S; Dixit M Dalton Trans; 2011 Jun; 40(23):6112-28. PubMed ID: 21541393 [TBL] [Abstract][Full Text] [Related]
8. Production of iodine-124 and its applications in nuclear medicine. Braghirolli AM; Waissmann W; da Silva JB; dos Santos GR Appl Radiat Isot; 2014 Aug; 90():138-48. PubMed ID: 24747530 [TBL] [Abstract][Full Text] [Related]
9. Positron Emission Tomography: applications in drug discovery and drug development. Wang J; Maurer L Curr Top Med Chem; 2005; 5(11):1053-75. PubMed ID: 16181131 [TBL] [Abstract][Full Text] [Related]
10. The role of radioisotopes in radiation oncology. Park CH Semin Oncol; 1997 Dec; 24(6):639-54. PubMed ID: 9422261 [TBL] [Abstract][Full Text] [Related]
12. Radiolabelling of peptides for diagnosis and therapy of non-oncological diseases. Sosabowsky J; Melendez-Alafort L; Mather S Q J Nucl Med; 2003 Dec; 47(4):223-37. PubMed ID: 14973415 [TBL] [Abstract][Full Text] [Related]
13. Current research in nuclear medicine and molecular imaging in Italy: highlights of the 10th National Congress of the Italian Association of Nuclear Medicine and Molecular Imaging. Cuocolo A Q J Nucl Med Mol Imaging; 2011 Jun; 55(3):280-300. PubMed ID: 21532541 [TBL] [Abstract][Full Text] [Related]
14. Radiometallated peptides for molecular imaging and targeted therapy. Correia JD; Paulo A; Raposinho PD; Santos I Dalton Trans; 2011 Jun; 40(23):6144-67. PubMed ID: 21350775 [TBL] [Abstract][Full Text] [Related]
18. Receptor imaging in oncology by means of nuclear medicine: current status. Van Den Bossche B; Van de Wiele C J Clin Oncol; 2004 Sep; 22(17):3593-607. PubMed ID: 15337810 [TBL] [Abstract][Full Text] [Related]
19. NK cell imaging by in vitro and in vivo labelling approaches. Galli F; Histed S; Aras O Q J Nucl Med Mol Imaging; 2014 Sep; 58(3):276-83. PubMed ID: 25265248 [TBL] [Abstract][Full Text] [Related]
20. Trends in nucleoside tracers for PET imaging of cell proliferation. Toyohara J; Fujibayashi Y Nucl Med Biol; 2003 Oct; 30(7):681-5. PubMed ID: 14499325 [No Abstract] [Full Text] [Related] [Next] [New Search]